Minimal residual disease tests provide an independent predictor of clinical outcome in adult acute lymphoblastic leukemia.
暂无分享,去创建一个
L. Foroni | H. Prentice | A. Goldstone | P. Gameiro | M. Papaioannou | F. Y. Mortuza | A. V. Hoffbrand | L. Coyle | D. Gandini | I. Moreira | A. Hoffbrand